Coble, M. G. | bioRxiv Science

bioRxiv2026

Altered astrocyte morphology in pathogenic HEPACAM variants: a multipoint analysis and new machine learning framework for 3D Sholl analysis

Astrocytes are morphologically complex glial cells that play critical roles in brain development and function. Altered astrocyte morphology is associated with altered astrocyte function and is a common feature of many neurological disorders. Astrocytes express numerous membrane proteins that are important for their morphogenesis, including hepaCAM, an astrocyte-enriched cell adhesion molecule that regulates astrocyte branching organization, tiling, and coupling. Pathogenic variants of HEPACAM that impair homophilic protein interaction cause megalencephalic leukoencephalopathy with subcortical cysts (MLC), a rare and early-onset leukodystrophy characterized by white matter edema, seizures, and cognitive and motor decline. Pathogenic variants show altered subcellular localization and impaired interaction with key binding partners, but the impact on astrocyte morphology remains unexplored. Here we expressed three different dominant pathogenic HEPACAM variants in astrocytes of the developing mouse cortex and performed a comprehensive multipoint analysis of astrocyte morphology. Using established analysis workflows and a new machine learning model for efficient 3D Sholl analysis, we found small, but significant increases in morphological complexity for the G89S pathogenic variant, which impairs homophilic cis interaction of hepaCAM, and the Q56P pathogenic variant, which impairs homophilic trans interaction. This phenotype is distinct from the morphological changes we previously observed in Hepacam knockout astrocytes, suggesting that dominant variants may impact astrocyte morphology through a gain-of-function, rather than a loss-of-function, mechanism. Our study also provides a new machine learning workflow for streamlined 3D analysis of astrocyte branching complexity along with a framework for performing multivariate analysis of astrocyte morphology metrics across multiple conditions.

neuroscience↗

bioRxiv2025

Dominant MLC-causing mutations alter hepaCAM subcellular localization and protein interactome in astrocytes of the developing mouse cortex

Megalencephalic leukoencephalopathy with subcortical cysts (MLC) is a rare leukodystrophy characterized by early-onset macrocephaly, white matter edema, seizures, and motor and cognitive decline. Missense mutations to hepatic and glial cell adhesion molecule (hepaCAM), also known as GlialCAM, are responsible for approximately twenty-five percent of MLC cases. HepaCAM is highly enriched in astrocytes and plays important roles in astrocyte territory establishment, gap junction coupling, branching organization, synaptic function, and development of the gliovascular unit. The molecular mechanisms through which MLC-causing missense mutations alter hepaCAM function in vivo and facilitate MLC pathogenesis during brain development remain largely unknown. Here, we used new viral tools and proximity-based proteomics to examine how three different dominant MLC-causing mutations impact hepaCAM subcellular localization and protein interactome in astrocytes of the developing mouse cortex. We found dramatic defects in hepaCAM distribution throughout the astrocyte, which were common to all mutants tested. We also observed significant changes in protein interactome between wild type and mutant hepaCAM, including decreased association with previously described hepaCAM-interacting proteins Connexin 43 and CLC-2. Moreover, we identified changes in association between hepaCAM and a number of previously undescribed potential hepaCAM-interaction partners, including the epilepsy-associated potassium channel KCNQ2. Collectively, our data provide new insights into hepaCAM function in astrocytes during brain development, reveal altered hepaCAM protein dynamics with MLC missense mutations, and provide a new resource to explore the molecular underpinnings of MLC pathogenesis.

neuroscience↗